Pressure-controlled intermittent coronary sinus occlusion (PiCSO) therapy added to primary PCI does not seem to reduce myocardial infarct size in patients with anterior ST-segment elevation myocardial ...

The augmentation index measured by using the central artery pressure is associated with an increased risk of coronary artery disease (CAD). However, no study has examined the role of the time duration ...

BOSTON, MA—One-year outcomes from an early feasibility study (EFS) show durable improvements in symptoms and quality of life in symptomatic heart failure (HF) patients treated with a novel coronary ...

The coronary sinus reducer (CSR), an hourglass-shaped stent that narrows the coronary sinus to increase coronary sinus pressure, has shown some promise in treating patients with refractory angina. But ...

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...

IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ensure ...